ConductScience.org, home

Paper39678564

Zoledronic acid improves periodontal health, reduces serum inflammation, and enhances bone metabolism in postmenopausal osteoporosis complicated by periodontitis.

Xu G and 5 others. Am J Transl Res, 2024. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Zoledronic acid improves periodontal health, reduces serum inflammation, and enhances bone metabolism in postmenopausal osteoporosis complicated by periodontitis. Papers, record 39678564. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39678564

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Zoledronic acid improves periodontal health, reduces serum inflammation, and enhances bone metabolism in postmenopausal osteoporosis complicated by periodontitis.
PubMed
Journal
Am J Transl Res
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
1.04, provisional
iCite
Revised in PubMed
2025-01-04
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Xu GGe
2Guo YYing
3Wang WWei
4Yu WQWan-Qiu
5Chen QMQian-Min
6Wang HHong

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137475545
Comparative evaluation of the clinical and radiographic efficacy of 0.05% zoledronate gel as local drug delivery system in treating intrabony defects in stage III grade B periodontitis patients with and without type-2 diabetes mellitus-A randomized split-mouth clinical trial.
Clin Adv Periodontics2024https://conductscience.org/library/papers/37475545PubMed
236299953Postmenopausal Osteoporosis: A Literature Review.Cureus2022https://conductscience.org/library/papers/36299953PubMed
317476007Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.N Engl J Med2007https://conductscience.org/library/papers/17476007PubMed
436433675Efficacy and Safety of Annual Infusion of Zoledronic Acid and Weekly Oral Alendronate in the Treatment of Primary Osteoporosis: A Meta-Analysis.J Clin Pharmacol2023https://conductscience.org/library/papers/36433675PubMed
520374619Association of physical exercise and calcium intake with bone mass measured by quantitative ultrasound.BMC Womens Health2010https://conductscience.org/library/papers/20374619PubMed
637559884Zoledronic acid for osteoporosis after distal radius fracture surgery: Prospective longitudinal study.J Orthop2023https://conductscience.org/library/papers/37559884PubMed
727696284Osteoporosis and Periodontitis.Curr Osteoporos Rep2016https://conductscience.org/library/papers/27696284PubMed
828317562Normal Oral Flora and the Oral Ecosystem.Dent Clin North Am2017https://conductscience.org/library/papers/28317562PubMed
935295207Prevalence of Osteoporosis Among Iranian Postmenopausal Women: A Systematic Review and Meta-analysis.Clin Med Insights Arthritis Musculoskelet Disord2022https://conductscience.org/library/papers/35295207PubMed
1038349271Combined chemotherapy of zoledronic acid and pamidronate in the treatment of bone metastases from nonsmall cell lung cancer and the effects on pain stress and bone metabolic indices.Drug Dev Res2024https://conductscience.org/library/papers/38349271PubMed
1134395641Prevalence of primary osteoporosis and low bone mass in postmenopausal women and related risk factors.J Educ Health Promot2021https://conductscience.org/library/papers/34395641PubMed
1237633518Zoledronic Acid Modulates Cytokine Expression and Mitigates Bone Loss during the Development of Induced Apical Periodontitis in a Mice Model.J Endod2023https://conductscience.org/library/papers/37633518PubMed
1333713186Effectiveness and safety of percutaneous kyphoplasty combined with zoledronic acid in treatment of osteoporotic vertebral compression fractures: a meta-analysis.Arch Orthop Trauma Surg2022https://conductscience.org/library/papers/33713186PubMed
1434387046The effects of zoledronic acid on the progression of experimental periodontitis in rats: histological and microtomographic analyses.J Periodontal Implant Sci2021https://conductscience.org/library/papers/34387046PubMed
1516798858Inflammation-induced bone remodeling in periodontal disease and the influence of post-menopausal osteoporosis.J Dent Res2006https://conductscience.org/library/papers/16798858PubMed
1635244945Osteoporosis and periodontal diseases - An update on their association and mechanistic links.Periodontol 20002022https://conductscience.org/library/papers/35244945PubMed
1734475752Retrospective Study of the Effects of Zoledronic Acid on Muscle Mass in Osteoporosis Patients.Drug Des Devel Ther2021https://conductscience.org/library/papers/34475752PubMed
1832615008Associations between osteoporosis and risk of periodontitis: A pooled analysis of observational studies.Oral Dis2021https://conductscience.org/library/papers/32615008PubMed
1933183112Pharmacological Management of Postmenopausal Osteoporosis: a Level I Evidence Based - Expert Opinion.Expert Rev Clin Pharmacol2021https://conductscience.org/library/papers/33183112PubMed
2028464230Patients with chronic periodontitis present increased risk for osteoporosis: A population-based cohort study in Taiwan.J Periodontal Res2017https://conductscience.org/library/papers/28464230PubMed

See all 29 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
41596243Research Advances in Bionic Cell Membrane-Mediated Nanodrug Delivery Systems for the Treatment of Periodontitis with Osteoporosis.Int J Mol Sci2026https://conductscience.org/library/papers/41596243PubMed
41415150Bisphosphonates and Periodontal Health: A Systematic Review in Postmenopausal Women.J Midlife Health2025https://conductscience.org/library/papers/41415150PubMed
41225098Periodontal Disease and Osteoporosis: A Bidirectional Relationship.Adv Exp Med Biol2026https://conductscience.org/library/papers/41225098PubMed
40869445Which Patients in the FLS Should Be Prioritised for a DXA Scan Within 12 Weeks?J Clin Med2025https://conductscience.org/library/papers/40869445PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BGLAP632PubTator's text mininghttps://conductscience.org/library/genes/632NCBI Gene
CRP1401PubTator's text mininghttps://conductscience.org/library/genes/1401NCBI Gene
IL1B3553PubTator's text mininghttps://conductscience.org/library/genes/3553NCBI Gene
TNF7124PubTator's text mininghttps://conductscience.org/library/genes/7124NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39678564

GET https://conductscience.org/api/papers/v1/39678564/references?page=2